Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient
Related Experiment Video
Updated: Feb 16, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
P Biondani1, E De Martin2, D Samuel2
1AP-HP Hôpital Paul-Brousse, Département d'Oncologie Médicale, Villejuif, F-94800, France.
No abstract available in PubMed .
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Survey Safety
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
What is the Immune System?
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...